Digital Journal — In southeastern England, a greenhouse sprawls across an acre of land. Electrified razor wire, video cameras and motion detectors surround the compound. Inside the air-filtered greenhouse, 15,000 marijuana plants grow under a 14-foot ceiling, comprising the potent strains known to most potheads: White Widow, Skunk, Northern Lights.
This is not some shady grow-op owned by paranoid dealers. Rather, it is the pot headquarters for GW Pharmaceuticals, an eight-year-old company that developed a cannabis-based spray to treat neuropathic pain.
This oral form of cannabis, and other new medicinal marijuana opportunities designed to dispel the reefer madness of yesteryear, are part of a growing trend to capitalize on ganja’s health benefits.
The cannabis business will find a home in pharmacies across the country, and much sooner than you might think…
This article is part of Digital Journal‘s Spring 2005 issue. To read the rest of this story, pick up your copy in bookstores across Canada or the United States!
